Literature DB >> 16996475

Signaling pathways regulating murine cardiac CREB phosphorylation.

Bailing Li1, Marcia A Kaetzel, John R Dedman.   

Abstract

Using the mouse Langendorff heart perfusion model, the signaling pathways that regulate cardiac CREB-S133 phosphorylation have been defined. In mouse hearts stimulated with isoproterenol (ISO) (10(-8) M), endothelin-1 (ET-1) (10(-8) M), and phorbol 12-myristate 13-acetate (TPA) (10(-7) M), CREB-S133 phosphorylation was attained only by TPA-treatment. Activation of protein kinase A (PKA) was achieved by ISO. ISO- and ET-1-stimulation activated Ca2+/calmodulin-dependent kinase II (CaMKII). Protein kinase C (PKC) and p90(RSK) were activated with all three stimuli. Inhibition of ERK1/2 with PD98059 (10(-5) M) completely inhibited the activation of p90(RSK), but did not block CREB-S133 phosphorylation in TPA-perfused heart, indicating that PKA, CaMKII, and p90(RSK) do not phosphorylate CREB-S133 in the murine heart. PKC activation is signal specific. Analyses of PKC isoforms suggest that CREB phosphorylation is mediated by PKC epsilon translocating into nucleus only with TPA stimulation. These results, unlike those reported in other tissues, demonstrate that cardiac CREB is not a multi-signal target.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16996475     DOI: 10.1016/j.bbrc.2006.09.016

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  MAP kinases in proliferating human colon cancer Caco-2 cells.

Authors:  Natalia Buzzi; Andrea Colicheo; Ricardo Boland; Ana Russo de Boland
Journal:  Mol Cell Biochem       Date:  2009-03-20       Impact factor: 3.396

Review 2.  Mechanisms of Cardiac Repair and Regeneration.

Authors:  Kathleen M Broughton; Bingyan J Wang; Fareheh Firouzi; Farid Khalafalla; Stefanie Dimmeler; Francisco Fernandez-Aviles; Mark A Sussman
Journal:  Circ Res       Date:  2018-04-13       Impact factor: 17.367

3.  Cross talk between PKC and CREB in the induction of COX-2 by PGF2α in human amnion fibroblasts.

Authors:  C M Guo; N Kasaraneni; K Sun; L Myatt
Journal:  Endocrinology       Date:  2012-08-23       Impact factor: 4.736

4.  Signaling pathways mediating beta3-adrenergic receptor-induced production of interleukin-6 in adipocytes.

Authors:  Inna E Tchivileva; Kai Soo Tan; Maria Gambarian; Andrea G Nackley; Alexander V Medvedev; Sergei Romanov; Patrick M Flood; William Maixner; Sergei S Makarov; Luda Diatchenko
Journal:  Mol Immunol       Date:  2009-05-23       Impact factor: 4.407

5.  Dipyridamole with low-dose aspirin augments the infarct size-limiting effects of simvastatin.

Authors:  Yumei Ye; Bo Long; Jinqiao Qian; Jose R Perez-Polo; Yochai Birnbaum
Journal:  Cardiovasc Drugs Ther       Date:  2010-12       Impact factor: 3.727

6.  Cyclic AMP Affects Oocyte Maturation and Embryo Development in Prepubertal and Adult Cattle.

Authors:  Sandra Milena Bernal-Ulloa; Julia Heinzmann; Doris Herrmann; Klaus-Gerd Hadeler; Patrick Aldag; Sylke Winkler; Dorit Pache; Ulrich Baulain; Andrea Lucas-Hahn; Heiner Niemann
Journal:  PLoS One       Date:  2016-02-29       Impact factor: 3.240

7.  C1q-TNF-related protein-3 attenuates pressure overload-induced cardiac hypertrophy by suppressing the p38/CREB pathway and p38-induced ER stress.

Authors:  Bing Zhang; Ping Zhang; Yanzhen Tan; Pan Feng; Zhengbin Zhang; Hongliang Liang; Weixun Duan; Zhenxiao Jin; Xiaowu Wang; Jincheng Liu; Erhe Gao; Shiqiang Yu; Dinghua Yi; Yang Sun; Wei Yi
Journal:  Cell Death Dis       Date:  2019-07-08       Impact factor: 8.469

Review 8.  Activation of PKC-ε counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members.

Authors:  A Gonelli; D Milani; E Rimondi; R Voltan; V Grill; C Celeghini
Journal:  Eur J Histochem       Date:  2009-09-30       Impact factor: 3.188

Review 9.  Counteracting Protein Kinase Activity in the Heart: The Multiple Roles of Protein Phosphatases.

Authors:  Silvio Weber; Stefanie Meyer-Roxlau; Michael Wagner; Dobromir Dobrev; Ali El-Armouche
Journal:  Front Pharmacol       Date:  2015-11-13       Impact factor: 5.810

10.  CHTM1, a novel metabolic marker deregulated in human malignancies.

Authors:  Mansi Babbar; Ying Huang; Jie An; Steve K Landas; M Saeed Sheikh
Journal:  Oncogene       Date:  2018-01-26       Impact factor: 9.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.